Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs Neostigmine/Atropine for POCD
NCT02419352Completed
- Sponsor
- Attikon University Hospital
- Start
- Sep 2010
- Primary completion
- Dec 2015
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Sugammadex in neuromuscular blockade (NMB) (2 arms), sponsored by Attikon University Hospital. Primary endpoints: Change in Mini-Mental State Evaluation, Change in Clock-drawing test and 1 more. Started Sep 2010; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT02419352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02419352.